Takeda Pharmaceutical (TAK) EBITDA Margin (2025)
Takeda Pharmaceutical has reported EBITDA Margin over the past 1 years, most recently at 18.36% for Q4 2025.
Takeda Pharmaceutical has reported EBITDA Margin over the past 1 years, most recently at 18.36% for Q4 2025.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month